McIlrath & Eck’s Sanofi SNY Stock Holding History

McIlrath & Eck’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-966	Closed	-$46.9K	–	990
2024 Q1	$46.9K	Buy	966 +353	+58%	+$17.2K	0.01%	284
2023 Q4	$30.5K	Buy	613 +361	+143%	+$17.7K	0.01%	334
2023 Q3	$13.5K	Hold	252	–	–	﹤0.01%	478
2023 Q2	$13.6K	Hold	252	–	–	﹤0.01%	499
2023 Q1	$13.7K	Buy	+252	New	+$12.3K	﹤0.01%	488
2022 Q2	–	Sell	-270	Closed	-$14K	–	872
2022 Q1	$14K	Hold	270	–	–	﹤0.01%	473
2021 Q4	$14K	Hold	270	–	–	﹤0.01%	485
2021 Q3	$13K	Hold	270	–	–	﹤0.01%	485
2021 Q2	$14K	Hold	270	–	–	﹤0.01%	468
2021 Q1	$13K	Hold	270	–	–	﹤0.01%	438
2020 Q4	$13K	Hold	270	–	–	﹤0.01%	373
2020 Q3	$14K	Hold	270	–	–	0.01%	324
2020 Q2	$14K	Sell	270 -70	-21%	-$3.4K	0.01%	301
2020 Q1	$15K	Buy	340 +70	+26%	+$3.35K	0.01%	246
2019 Q4	$14K	Hold	270	–	–	0.01%	308
2019 Q3	$13K	Hold	270	–	–	0.01%	298
2019 Q2	$12K	Hold	270	–	–	0.01%	296
2019 Q1	$12K	Sell	270 -353	-57%	-$15.1K	0.01%	296
2018 Q4	$27K	Hold	623	–	–	0.02%	160
2018 Q3	$28K	Hold	623	–	–	0.02%	172
2018 Q2	$25K	Buy	+623	New	+$24.5K	0.02%	171

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

McIlrath & Eck's SNY Position: Q2 2024 in Review

McIlrath & Eck sold out of Sanofi (SNY) in Q2 2024, closing a stake of 966 shares — an estimated $46.9K sold.

McIlrath & Eck first reported a position in SNY in Q2 2018 and held it in 21 quarters. The position peaked at $46.9K in Q1 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

McIlrath & Eck reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
McIlrath & Eck sold 966 Sanofi shares in Q2 2024, an estimated $46.9K.
McIlrath & Eck first reported a position in Sanofi in Q2 2018 and held it in 21 quarters.
McIlrath & Eck's Sanofi position peaked at $46.9K in Q1 2024.
730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on McIlrath & Eck's 13F filing for Q2 2024, filed 14 Aug 2024.